🔎 Trials Near Me

Akèy › Kansè nan tete › Nevada › Las Vegas

Etid klinik pou Kansè nan tete nan Las Vegas, NV

10 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Las Vegas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • OptumCare Cancer Care at Charleston, Las Vegas
  • University Medical Center of Southern Nevada, Las Vegas
  • Hope Cancer Care of Nevada, Las Vegas
  • ak 16 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Ap rekriteFaz 3
  • Optum Care Cancer Center ( Site 0050), Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06966700

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Ap rekriteFaz 3
  • OptumCare Cancer Care at Charleston, Las Vegas
  • University Medical Center of Southern Nevada, Las Vegas
  • Hope Cancer Care of Nevada, Las Vegas
  • ak 16 plis
Laj 18 a 60 · Fanm · Mizajou Sep 2, 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1
  • Comprehensive Cancer Centers of Nevada, Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07029399

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Ap rekriteFaz 2
  • Comprehensive Cancer Centers of Nevada, Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06764940

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Ap rekriteFaz 1/2
  • Comprehensive Cancer Centers of Nevada, Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05377996

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Ap rekriteFaz 3
  • Comprehensive Cancer Centers of Nevada, Las Vegas
  • Comprehensive Cancer Centers of Nevada, Las Vegas
  • Comprehensive Cancer Centers of Nevada, Las Vegas
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Ap rekriteFaz 3
  • OptumCare Cancer Care at Charleston, Las Vegas
  • Radiation Oncology Centers of Nevada Central, Las Vegas
  • Radiation Oncology Centers of Nevada Southeast, Las Vegas
  • ak 6 plis
Laj 50 a 70 · Tout sèks · Mizajou Apr 23, 2026 · NCT04852887

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

Ap rekriteFaz 1
  • Comprehensive Cancer Centers of Nevada, Las Vegas
Laj 18 ak plis · Fanm · Mizajou Apr 22, 2026 · NCT05683418

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ap rekriteEtid obsèvasyon
  • OptumCare Cancer Care at Charleston, Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT06418204

Etid Kansè nan tete nan lòt vil

Lòt etid nan Las Vegas

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.